The Opening and Closing of Empiric Windows: The Impact of Rapid Microbiologic Diagnostics

Authors:

Abstract
To the Editor—With the advent of rapid diagnostic techniques for pathogen identification, clinicians are encountering increasing windows of time when they are aware of an infecting organism's species without yet knowing its susceptibilities [1, 2]. We believe that it is worthwhile to formally recognize these empiric windows in the management of infectious diseases (Figure 1). These windows include infectious syndrome–guided therapy (empiric window 1), Gram stain morphology–guided therapy (empiric window 2), and pathogen-guided therapy (empiric window 3), before, finally, susceptibility-guided therapy.